Related Experiment Videos
Treatment of human immunodeficiency virus infections
Antimicrobial Agents and Chemotherapy
|June 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
Brain : a journal of neurology·2005
Pseudo-metabolic presentation in a Duchenne muscular dystrophy symptomatic carrier with 'de novo' duplication of dystrophin gene.
Neuromuscular disorders : NMD·2001
Genomics and medicine: an anticipation. From Boolean Mendelian genetics to multifactorial molecular medicine.
Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie·2001
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
Rituximab-Based Therapy in IgA Nephropathy With Crescents: A Comparative Study.
Clinical therapeutics·2026
Pulmonary nocardiosis following pembrolizumab use: case report and literature review of nocardiosis associated with immune checkpoint inhibitors.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
High-throughput primary B cell cytokines assay for drug screening in multiple sclerosis.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026